Skip to main content

A Review of the Use of Anti-vascular Endothelial Growth Factor Drugs at the Eye Foundation Centre for the Prevention of Blindness, Nigeria | Chapter 06 | New Insights into Disease and Pathogen Research Vol. 3

Aims: To describe the sociodemographic details and indications for the use of anti-vascular endothelial growth factor (anti-VEGF) injections at the Eye Foundation Centres in Nigeria.

Study Design: Retrospective, observational analysis.

Place and Duration of Study: Eye Foundation Hospitals in Lagos, Ijebu-Imushin and Abuja, Nigeria between January 2011 and December 2014.

Methods: Records of all anti-VEGF injections given were assessed. All consecutive cases were taken in proportion seen in the 4 centres. Age, sex, occupation, diagnoses and types of injection were recorded in the data sheet prepared for the study.

 Results: This study included 1072 eyes of 540 patients. Mean age was 60.37(12.74) standard deviation years. The age range is from 10 – 92 years. 326(60.4%) males and females 214(39.6%) were seen. Patients that presented were mostly currently employed 40.8%, previously in paid job 25.8% and businessmen and women 24.5%. Total injections were 2443, given during the study period. Anti-VEGF agents used were Bevacizumab (2278; 93.2%) and Ranibizumab (165; 6.8%).

Indications for injection were: proliferative diabetic retinopathy (PDR) 27.4%, retinal vein occlusion (RVO) 17.6% and vitreous haemorrhage (VH) due to proliferative diabetic retinopathy and sickle cell retinopathy 10.6%. There was an association between sex and disease (p < 0.001) and age and disease (p < 0.001).

Conclusion: The use of anti-VEGF injections are on the increase especially bevacizumab. The most common indications are proliferative diabetic retinopathy, retinal vein occlusion and VH. The treatment was done more for males, middle class and the rich.

Author(s) Details

Tayo Julius Bogunjoko
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Dr. Adekunle Hassan, MD. FRCS, FRCOph, FWACS, FNICM
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Dr. Olufemi Oderinlo
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Okonkwo Ogugua
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Mildred Ulaikere
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Toyin Akanbi
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

Abimbola Ashaye
Eye Foundation Centre for the Prevention of Blindness, Nigeria.

View Books: http://bp.bookpi.org/index.php/bpi/catalog/book/112
Labels:

Comments

Post a Comment

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)
Post a Comment
Read more

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system
Post a Comment
Read more

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent
Post a Comment
Read more